Inscription Capital LLC Purchases Shares of 36,307 Colgate-Palmolive (NYSE:CL)

Inscription Capital LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 36,307 shares of the company's stock, valued at approximately $3,269,000.

Other hedge funds have also modified their holdings of the company. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $27,000. Vermillion Wealth Management Inc. bought a new position in Colgate-Palmolive in the fourth quarter valued at approximately $31,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. Finally, Briaud Financial Planning Inc bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Down 0.2%

NYSE CL opened at $90.10 on Tuesday. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a 50 day moving average of $91.78 and a 200-day moving average of $90.95. The company has a market cap of $73.02 billion, a price-to-earnings ratio of 25.60, a PEG ratio of 4.20 and a beta of 0.38.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The company's quarterly revenue was down 3.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.86 EPS. On average, equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.31%. Colgate-Palmolive's payout ratio is 58.76%.

Colgate-Palmolive announced that its Board of Directors has authorized a share buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to reacquire up to 6.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's management believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. UBS Group boosted their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a report on Wednesday, April 2nd. JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. Finally, Barclays dropped their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of "Hold" and an average price target of $102.12.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.